Nasdaq Biotechnology Ishares (IBB) 259.09 $IBB
Do Illumina and Incyte Belong in Your Portfolio?
Selena Maranjian, The Motley Fool - Motley Fool - Mon Jul 07, 5:15PM CDT
Source: Konrad Forstner, Wikimedia Commons. Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some biotech companies to your portfolio but don't have the time or expertise to...
12.9% Return Seen to Date on SmarTrend iShares Nasdaq Biotechnology Index Call (IBB)
Comtex SmarTrend(R) - Wed Jul 02, 9:22AM CDT
SmarTrend identified an Uptrend for iShares Nasdaq Biotechnology Index (AMEX:IBB) on April 22nd, 2014 at $232.92. In approximately 2 months, iShares Nasdaq Biotechnology Index has returned 12.92% as of today's recent price of $263.01.
SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 2.37% Gain
Comtex SmarTrend(R) - Tue Jul 01, 4:46PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $258.18 to a high of $263.30. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $258.12 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Watch for iShares Nasdaq Biotechnology Index to Potentially Pullback After Gaining 2.37% Yesterday
Comtex SmarTrend(R) - Tue Jul 01, 4:45PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $258.18 to a high of $263.30. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $258.12 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
3 Stocks Tumbling This Month: Clovis Oncology, Hyperion Therapeutics, and Puma Biotechnology
Todd Campbell, The Motley Fool - Motley Fool - Mon Jun 30, 3:12PM CDT
Shares in biotechnology companies can make breathtaking moves higher and lower on whims and whispers and June was no exception. Following a rollicking ride higher last year and dramatic sell-off in the first quarter, investors are right to be...
3 Stocks With Eye-Popping Gains This Month
Todd Campbell, The Motley Fool - Motley Fool - Mon Jun 30, 2:12PM CDT
Shares in biotechnology companies can make breathtaking moves higher and lower on whims and whispers, and June was no exception. Following the sector's rollicking ride higher last year and dramatic sell-off in the first quarter, investors are right...
Vertex Pharma Pushes Biotech ETFs Higher - ETF News And Commentary
Sweta Killa - ZACKS - Wed Jun 25, 1:00PM CDT
The positive trial results of a cystic fibrosis send Vertex Pharmaceuticals and these biotech ETFs higher on Tuesday trading session.
'Fast Money' Recap: A Mixed Bag for Housing
at The Street - Wed Jun 25, 4:00AM CDT
The trading panel discussed the stock market's big drop, how low the S&P can go and why bonds aren't selling off.
iShares Nasdaq Biotechnology Index Rises 1.02% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Jun 24, 4:01PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $254.36 to a high of $259.87. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $256.73 on volume of 1.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Pullback after Yesterday's 1.02% Rise
Comtex SmarTrend(R) - Tue Jun 24, 4:00PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $254.36 to a high of $259.87. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $256.73 on volume of 1.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
How Will Biotechnology ETFs Finish Out the Year? - ETF News And Commentary
Zacks Equity Research - ZACKS - Tue Jun 24, 9:00AM CDT
Which trend will prevail in the volatile biotechnology ETF space.
Two Reasons the Stock Market Is Really Different This Time
at The Street - Mon Jun 23, 11:05AM CDT
The market nowadays is not following any historical trend. Here's why.
iShares Nasdaq Biotechnology Index Set to Possibly Pullback After Yesterday's Rally of 2.03%
Comtex SmarTrend(R) - Fri Jun 20, 3:56PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $250.85 to a high of $255.64. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $251.16 on volume of 1.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Two Biotech ETFs Surge on Idenix-Merck Deal - ETF News And Commentary
Sweta Killa - ZACKS - Tue Jun 10, 1:00PM CDT
Idenix Pharmaceuticals pushes these two biotech ETFs higher ahead of the rivals on Merck buyout.
Jim Cramer's 'Mad Money' Recap: Fewer Jobs = Bull Market
at The Street - Wed Jun 04, 7:10PM CDT
Disbelief is a hallmark of a powerful bull market, Cramer says. Nowhere is that disbelief stronger than in the notion that fewer jobs are better for stock prices.
Do Illumina and Incyte Belong in Your Portfolio?
Selena Maranjian, The Motley Fool - Motley Fool - Mon Jul 07, 5:15PM CDT
Source: Konrad Forstner, Wikimedia Commons. Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some biotech companies to your portfolio but don't have the time or expertise to...
12.9% Return Seen to Date on SmarTrend iShares Nasdaq Biotechnology Index Call (IBB)
Comtex SmarTrend(R) - Wed Jul 02, 9:22AM CDT
SmarTrend identified an Uptrend for iShares Nasdaq Biotechnology Index (AMEX:IBB) on April 22nd, 2014 at $232.92. In approximately 2 months, iShares Nasdaq Biotechnology Index has returned 12.92% as of today's recent price of $263.01.
SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 2.37% Gain
Comtex SmarTrend(R) - Tue Jul 01, 4:46PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $258.18 to a high of $263.30. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $258.12 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Watch for iShares Nasdaq Biotechnology Index to Potentially Pullback After Gaining 2.37% Yesterday
Comtex SmarTrend(R) - Tue Jul 01, 4:45PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $258.18 to a high of $263.30. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $258.12 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
3 Stocks Tumbling This Month: Clovis Oncology, Hyperion Therapeutics, and Puma Biotechnology
Todd Campbell, The Motley Fool - Motley Fool - Mon Jun 30, 3:12PM CDT
Shares in biotechnology companies can make breathtaking moves higher and lower on whims and whispers and June was no exception. Following a rollicking ride higher last year and dramatic sell-off in the first quarter, investors are right to be...
3 Stocks With Eye-Popping Gains This Month
Todd Campbell, The Motley Fool - Motley Fool - Mon Jun 30, 2:12PM CDT
Shares in biotechnology companies can make breathtaking moves higher and lower on whims and whispers, and June was no exception. Following the sector's rollicking ride higher last year and dramatic sell-off in the first quarter, investors are right...
Vertex Pharma Pushes Biotech ETFs Higher - ETF News And Commentary
Sweta Killa - ZACKS - Wed Jun 25, 1:00PM CDT
The positive trial results of a cystic fibrosis send Vertex Pharmaceuticals and these biotech ETFs higher on Tuesday trading session.
'Fast Money' Recap: A Mixed Bag for Housing
at The Street - Wed Jun 25, 4:00AM CDT
The trading panel discussed the stock market's big drop, how low the S&P can go and why bonds aren't selling off.
iShares Nasdaq Biotechnology Index Rises 1.02% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Jun 24, 4:01PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $254.36 to a high of $259.87. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $256.73 on volume of 1.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Pullback after Yesterday's 1.02% Rise
Comtex SmarTrend(R) - Tue Jun 24, 4:00PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $254.36 to a high of $259.87. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $256.73 on volume of 1.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
How Will Biotechnology ETFs Finish Out the Year? - ETF News And Commentary
Zacks Equity Research - ZACKS - Tue Jun 24, 9:00AM CDT
Which trend will prevail in the volatile biotechnology ETF space.
Two Reasons the Stock Market Is Really Different This Time
at The Street - Mon Jun 23, 11:05AM CDT
The market nowadays is not following any historical trend. Here's why.
iShares Nasdaq Biotechnology Index Set to Possibly Pullback After Yesterday's Rally of 2.03%
Comtex SmarTrend(R) - Fri Jun 20, 3:56PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $250.85 to a high of $255.64. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $251.16 on volume of 1.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Two Biotech ETFs Surge on Idenix-Merck Deal - ETF News And Commentary
Sweta Killa - ZACKS - Tue Jun 10, 1:00PM CDT
Idenix Pharmaceuticals pushes these two biotech ETFs higher ahead of the rivals on Merck buyout.
Jim Cramer's 'Mad Money' Recap: Fewer Jobs = Bull Market
at The Street - Wed Jun 04, 7:10PM CDT
Disbelief is a hallmark of a powerful bull market, Cramer says. Nowhere is that disbelief stronger than in the notion that fewer jobs are better for stock prices.
